142 related articles for article (PubMed ID: 8186321)
21. Clinicopathologic, immunophenotypic and ultrastructrual analyses of ATLL patients with cutaneous involvement.
Wang C; Yao Z; Liao J; Luo Y; Ma Y; Chen G; Zhu W
Chin Med J (Engl); 1999 May; 112(5):461-5. PubMed ID: 11593520
[TBL] [Abstract][Full Text] [Related]
22. Immunoregulatory events in the skin of patients with cutaneous T-cell lymphoma.
Hansen ER
Arch Dermatol; 1996 May; 132(5):554-61. PubMed ID: 8624153
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
25. The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides.
Wenzel J; Gütgemann I; Distelmaier M; Uerlich M; Mikus S; Bieber T; Tüting T
J Am Acad Dermatol; 2005 Sep; 53(3):422-7. PubMed ID: 16112347
[TBL] [Abstract][Full Text] [Related]
26. Detection of clonal T cells in cutaneous T cell lymphoma by polymerase chain reaction: comparison of mutation detection enhancement-polyacrylamide gel electrophoresis, temperature gradient gel electrophoresis and fragment analysis of sequencing gels.
Scheller U; Muche JM; Sterry W; Lukowsky A
Electrophoresis; 1998 May; 19(5):653-8. PubMed ID: 9629892
[TBL] [Abstract][Full Text] [Related]
27. BAFF levels are increased in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Miyagaki T; Suga H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Br J Dermatol; 2012 Aug; 167(2):359-67. PubMed ID: 22512719
[TBL] [Abstract][Full Text] [Related]
28. The applicability of T-cell receptor gamma gene rearrangement as an adjuvant diagnostic tool in skin biopsies for cutaneous T-cell lymphoma.
Khalil SH; Hamadah IR
Saudi Med J; 2006 Jul; 27(7):951-4. PubMed ID: 16830010
[TBL] [Abstract][Full Text] [Related]
29. T-cell technology in the diagnosis & management of cutaneous T-cell lymphoma.
Duncan KO; Heald PW
Compr Ther; 1998 Mar; 24(3):117-22. PubMed ID: 9559245
[TBL] [Abstract][Full Text] [Related]
30. No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma.
Böni R; Davis-Daneshfar A; Burg G; Fuchs D; Wood GS
Br J Dermatol; 1996 Feb; 134(2):282-4. PubMed ID: 8746342
[TBL] [Abstract][Full Text] [Related]
31. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
32. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous T-cell lymphoma sparing resolving dermatomal herpes zoster lesions: an unusual phenomenon and implications for pathophysiology.
Twersky JM; Nordlund JJ
J Am Acad Dermatol; 2004 Jul; 51(1):123-6. PubMed ID: 15243537
[TBL] [Abstract][Full Text] [Related]
34. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas: stage-dependent increase in mycosis fungoides progression.
Asadullah K; Haeussler-Quade A; Gellrich S; Hanneken S; Hansen-Hagge TE; Döcke WD; Volk HD; Sterry W
Exp Dermatol; 2000 Aug; 9(4):248-51. PubMed ID: 10949545
[TBL] [Abstract][Full Text] [Related]
35. Epidermal interleukin 1 alpha functional activity and interleukin 8 immunoreactivity are increased in patients with cutaneous T-cell lymphoma.
Hansen ER; Vejlsgaard GL; Lisby S; Heidenheim M; Baadsgaard O
J Invest Dermatol; 1991 Nov; 97(5):818-23. PubMed ID: 1919047
[TBL] [Abstract][Full Text] [Related]
36. Delta chain-positive T-cell lymphoma of the skin.
Crosti L; Roscetti E; Berti E
Dermatol Clin; 1994 Apr; 12(2):391-7. PubMed ID: 8045050
[TBL] [Abstract][Full Text] [Related]
37. Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3/Stat3 signaling pathway.
Krejsgaard T; Ralfkiaer U; Clasen-Linde E; Eriksen KW; Kopp KL; Bonefeld CM; Geisler C; Dabelsteen S; Wasik MA; Ralfkiaer E; Woetmann A; Odum N
J Invest Dermatol; 2011 Jun; 131(6):1331-8. PubMed ID: 21346774
[TBL] [Abstract][Full Text] [Related]
38. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.
Kopp KL; Ralfkiaer U; Nielsen BS; Gniadecki R; Woetmann A; Ødum N; Ralfkiaer E
APMIS; 2013 Nov; 121(11):1020-4. PubMed ID: 24033365
[TBL] [Abstract][Full Text] [Related]
39. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
[TBL] [Abstract][Full Text] [Related]
40. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]